Movicol Junior Chocolate

Macrogol 3350, the active ingredient in Movicol Junior Chocolate, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation in children and helps to soften stool and promote regular bowel movements.

GNH USA supplies Movicol Junior Chocolate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring product integrity from manufacture to delivery.

Movicol Junior Chocolate, an osmotic laxative, is used to treat constipation in pediatric patients. - Constipation: softens stool and facilitates bowel movements in children with functional or chronic constipation. - Encopresis associated with constipation: helps relieve fecal impaction and improves stool passage. - Post‑operative constipation: aids in restoring normal bowel function after surgical procedures in young patients.

The most frequently reported reactions to Movicol Junior Chocolate are generally mild and transient.

Common Side Effects: - Abdominal discomfort: mild cramps or pain that usually resolve without treatment. - Diarrhoea: loose, watery stools that may appear shortly after dosing. - Nausea: transient feeling of sickness that often subsides quickly. - Bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas leading to belching or passing gas.

Serious or Rare Side Effects: - Severe dehydration: significant fluid loss that may need medical rehydration. - Electrolyte imbalance: abnormal sodium or potassium levels that can affect heart rhythm. - Allergic reaction: rash, itching, swelling, or breathing difficulty indicating hypersensitivity. - Persistent abdominal pain: severe or worsening pain that does not improve. - Blood in stool: presence of fresh blood suggesting gastrointestinal injury.

When using Movicol Junior Chocolate, certain precautions should be observed to ensure safety. - Assess hydration status: confirm the child is adequately hydrated before initiating therapy. - Monitor electrolyte levels: check sodium and potassium concentrations during prolonged use. - Adjust dose in renal impairment: reduce or avoid use if kidney function is compromised. - Seek medical advice for gastrointestinal disease: obtain clinician guidance if the child has inflammatory bowel disease or obstruction. - Observe for signs of dehydration: watch for excessive thirst, dry mouth, or reduced urine output. - Store at ambient temperature: keep the solution below 25°C in the original container, protected from moisture and direct sunlight.

Movicol Junior Chocolate may interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative effect, leading to inadequate relief. - Digoxin: increased risk of electrolyte disturbances that can potentiate cardiac toxicity. - Loop diuretics: combined use may exacerbate fluid and electrolyte loss. - Iron supplements: may reduce absorption of the laxative, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Oral electrolyte supplements: may alter the intended osmotic balance, requiring dose adjustment. - Other laxatives: concurrent use can increase risk of diarrhoea and dehydration. - NSAIDs: may increase risk of renal impairment when combined with osmotic laxatives. - Antibiotics (e.g., tetracycline): may have altered absorption due to changed gut transit. - Antihypertensive agents: monitor blood pressure as fluid shifts could affect control.